Aldeyra Therapeutics, Inc. Insider Trading for September 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aldeyra Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aldeyra Therapeutics, Inc. for September 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 25 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.81 | 8,680 | 50,433 | 623,506 | 614.8 K to 623.5 K (+1.41 %) |
| Sep 20 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.91 | 14,288 | 84,465 | 614,826 | 600.5 K to 614.8 K (+2.38 %) |
| Sep 19 2019 | ALDX | Aldeyra Therapeuti ... | Bronstein Ben | Director | Buy | P | 5.85 | 1,700 | 9,945 | 18,644 | 16.9 K to 18.6 K (+10.03 %) |
| Sep 17 2019 | ALDX | Aldeyra Therapeuti ... | DOUGLAS RICHARD | Director | Buy | P | 6.00 | 5,000 | 30,000 | 85,000 | 80 K to 85 K (+6.25 %) |
| Sep 17 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 6.03 | 3,000 | 18,090 | 591,991 | 589 K to 592 K (+0.51 %) |
| Sep 17 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.79 | 10,000 | 57,900 | 588,991 | 579 K to 589 K (+1.73 %) |
| Sep 16 2019 | ALDX | Aldeyra Therapeuti ... | JOYCE MARTIN JOSEPH | Director | Buy | P | 5.86 | 1,700 | 9,964 | 19,644 | 17.9 K to 19.6 K (+9.47 %) |
| Sep 13 2019 | ALDX | Aldeyra Therapeuti ... | DOUGLAS RICHARD | Director | Buy | P | 6.03 | 10,000 | 60,276 | 80,000 | 70 K to 80 K (+14.29 %) |
| Sep 13 2019 | ALDX | Aldeyra Therapeuti ... | DOUGLAS RICHARD | Director | Buy | P | 5.75 | 10,000 | 57,529 | 70,000 | 60 K to 70 K (+16.67 %) |
| Sep 11 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 5.39 | 10,000 | 53,937 | 578,991 | 569 K to 579 K (+1.76 %) |
| Sep 11 2019 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Buy | P | 4.89 | 10,000 | 48,887 | 568,991 | 559 K to 569 K (+1.79 %) |
| Sep 11 2019 | ALDX | Aldeyra Therapeuti ... | DOUGLAS RICHARD | Director | Buy | P | 5.09 | 10,000 | 50,857 | 60,000 | 50 K to 60 K (+20.00 %) |
| Sep 11 2019 | ALDX | Aldeyra Therapeuti ... | DOUGLAS RICHARD | Director | Buy | P | 4.91 | 10,000 | 49,106 | 50,000 | 40 K to 50 K (+25.00 %) |
| Sep 10 2019 | ALDX | Aldeyra Therapeuti ... | Clark David J | Chief Medical Offic ... | Buy | P | 5.06 | 5,000 | 25,311 | 17,878 | 12.9 K to 17.9 K (+38.83 %) |
| Sep 09 2019 | ALDX | Aldeyra Therapeuti ... | Reed Joshua | Chief Financial Off ... | Buy | P | 4.71 | 3,200 | 15,072 | 35,774 | 32.6 K to 35.8 K (+9.82 %) |
| Sep 09 2019 | ALDX | Aldeyra Therapeuti ... | McMullin David | Chief Commerical Of ... | Buy | P | 4.68 | 4,329 | 20,260 | 6,148 | 1.8 K to 6.1 K (+237.99 %) |